Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biosearch Announces Acquisition of European Companies DNA Technology and VitraBio

Published: Tuesday, July 23, 2013
Last Updated: Tuesday, July 23, 2013
Bookmark and Share
Acquisition marks Company’s increasing commitment to support European biotechnology and diagnostic markets.

Biosearch Technologies, Inc. (Biosearch) has announced that it has acquired the oligonucleotide manufacturing division of the Danish company DNA Technology A/S (DNA Technology) and German CPG manufacturer VitraBio GmbH (VitraBio).

With the acquisition of DNA Technology, Biosearch has added a highly skilled production team with a mature quality system and an established European customer base focused in the Nordic countries.

DNA Technology specializes in production of modified oligos, and will benefit from full access to the breadth of specialty modifications produced by Biosearch.

In addition, Biosearch will provide manufacturing tools and access to its substantial IP portfolio enabling DNA Technology to expand production capabilities and product offerings in order to better serve an expanding customer base.

With the acquisition of German controlled-pore glass (CPG) manufacturer VitraBio in September 2011, Biosearch gains control over VitraBio’s sophisticated CPG manufacturing technology and unique production facility, which expands its already extensive repertoire of oligo synthesis tools and processes.

In addition to continuing production of DNA/RNA synthesis supports for the research and therapeutic oligo markets, Biosearch intends to bring chemical manufacturing capabilities to VitraBio’s Steinach facility to supplement existing US production of specialty amidites and modified CPGs.

The acquisition of DNA Technology and VitraBio marks Biosearch’s increasing commitment to support European biotechnology and diagnostic markets.

Furthermore, Biosearch has secured important manufacturing redundancy for its North American operations as well as a strong base from which to grow sales, production and regulated contract manufacturing capabilities throughout Europe.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biosearch Technologies Awarded Second Phase II Army SBIR Grant
The $750,000+ Phase II grant will continue the design and development of accurate assays for pathogens of military importance.
Thursday, October 14, 2010
Biosearch Expands Licensing of Roche Patents to Manufacture Kits Targeting the in-vitro Diagnostic Industry
License allows Biosearch to develop kits comprising of probes, primers, enzymes to amplify and detect diagnostic targets.
Wednesday, March 10, 2010
Biosearch Technologies Issued Two new Patents
The new patents comprise “Luminescent Metal Ion Complexes” and “Inducible fluorescence assay.”
Tuesday, March 09, 2010
CAL FluorR Patent Issued to Biosearch Technologies
Company has been awarded U.S. Patent describing the CAL Fluor® series of fluorescent dyes for modifying synthetic DNA to enhance its detectability.
Wednesday, April 02, 2008
Phase I and II SBIR Grants Issued to Biosearch
Biosearch’s two staff scientists have been awarded SBIR grants totaling $850,000 by the National Institutes of Health in Bethesda.
Monday, June 18, 2007
BHQ® Patent Issued to Biosearch Technologies
Biosearch now licenses the BHQ technology to major custom oligo providers in the U.S. and Europe.
Monday, April 24, 2006
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Study Finds Non-Genetic Cancer Mechanism
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
The Mystery of the Instant Noodle Chromosomes
Researchers from the Lomonosov Moscow State University evaluated the benefits of placing the DNA on the principle of spaghetti.
Oxitec ‘Self-Limiting Gene’ Offers Hope for Controlling Invasive Moth
A new pesticide-free and environmentally-friendly way to control insect pests has moved ahead with the publication of results showing that Oxitec diamondback moths (DBM) with a ‘self-limiting gene’ can dramatically reduce populations of DBM.
Web App Helps Researchers Explore Cancer Genetics
Brown University computer scientists have developed a new interactive tool to help researchers and clinicians explore the genetic underpinnings of cancer.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!